A defibrillator is a medical device that is used to deliver an electrical shock to the heart. The shock is intended to correct irregular electrical activity of the heart and to establish an organized rhythm. The defibrillator market in Europe is anticipated to reach valuation of ~USD 4,019 百万 2027, 代表复合年增长率 4.9% 从 2021 到 2027 根据Gen Consulting公司的最新报告.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into defibrillator market in Europe. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the defibrillator industry.

The defibrillator market is segmented on the basis of product, 最终用户, 和国家. The defibrillator market is segmented as below:

副产品:
– implantable cardioverter defibrillator (transvenous ICD, subcutaneous ICD)
– external defibrillator (手动的, fully automated external defibrillators, wearable)

按最终用户:
– alternate care facilities
– homecare
– 医院 & 诊所
– pre hospital
– public access

按国家/地区:
– 德国
– 英国
– 法国
– 意大利
– 西班牙
– 欧洲其他地区

The report has also analysed the competitive landscape of the defibrillator market in Europe with some of the key players being Abbott Laboratories, Biotronik SE & Co KG, 波士顿科学公司, CU Medical Systems, 公司, 皇家飞利浦公司, 美敦力公司, Mindray Medical International Limited, 日本光电株式会社, Progetti S.r.l., ZOLL Medical Corporation, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2017 到 2027 考虑到 2020 为基准年.

报告范围
– To analyze and forecast the market size of the defibrillator market in Europe.
– To classify and forecast the defibrillator market in Europe based on product, 最终用户, 和国家.
– To identify drivers and challenges for the defibrillator market in Europe.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the defibrillator market in Europe.
– To identify and analyze the profile of leading players operating in the defibrillator market in Europe.

为什么选择这份报告
– Gain a reliable outlook of the defibrillator market in Europe forecasts from 2021 到 2027 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.